-
These Companies Probably Won't Be Acquiring Ariad Pharmaceuticals
Saturday, April 18, 2015 - 10:49am | 338Adam Feuerstein was recently a guest on #PreMarket Prep, a daily trading idea radio show hosted by Joel Elconin and Dennis Dick. TheStreet Senior Columnist Adam Feuerstein responded to an article in the Boston Business Journal which suggested that Ariad Pharmaceuticals, Inc. (NASDAQ: ARIA)...
-
Biogen Investors: Active Ingredient In Patient Death Is Not Changing BofA's Forecast
Thursday, April 9, 2015 - 12:20pm | 214Bank of America commented on Biogen Inc (NASDAQ: BIIB) Wednesday following the death of a patient due to fatal progressive multifocal leukoencephalopathy (PML) that was linked to dimethyl fumarate (DMF). Dimethyl fumarate is the active ingredient in Biogen’s multiple sclerosis drug,...